GSK-3β Inhibitor II

• CAT Number: I011612
• CAS Number: 478482-75-6
• Molecular Formula: C14H10IN3OS
• Molecular Weight: 395.218
• Purity: ≥95%
• Synonyms: 4-[5-[[(3-iodophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]-pyridine
• Target: GSK-3
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: 2-[(3-iodophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole
• InChI: InChI=1S/C14H10IN3OS/c15-12-3-1-2-10(8-12)9-20-14-18-17-13(19-14)11-4-6-16-7-5-11/h1-8H,9H2
• InChIKey: ZRHRPGSSSVYBRG-UHFFFAOYSA-N
• SMILES: C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3

GSK-3β Inhibitor II(CAT: I011612) is a small molecule compound that functions as an inhibitor of glycogen synthase kinase-3 beta (GSK-3β), which is a serine/threonine protein kinase that plays a role in various signaling pathways in the body. GSK-3β is involved in regulating glycogen metabolism, protein synthesis, cell proliferation, and apoptosis, among other functions. By inhibiting GSK-3β activity, this compound has potential therapeutic applications in treating a range of diseases, including neurodegenerative disorders, cancer, and diabetes. It is typically used as a tool compound in laboratory research to study GSK-3β signaling pathways and their downstream effects.